glp-1 rfk jr FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures RFK Jr. discusses GRAS &

In the TOGETHER-PsA trial, Merola and colleagues assessed the efficacy and safety of combination therapy with ixekizumab (Taltz, Eli Lilly) plus tirzepatide (Zepbound, Eli Lilly), compared with ixekizumab alone in a cohort of 271 adults with active PsA and overweight or obesity, aligned with the on-label dosing of both interventions

One effective method to address this deficiency is through B12 injections

Chitosan-graft-polyethylenimine/DNA nanoparticles as novel non-viral gene delivery vectors targeting osteoarthritis

Novo Nordisk has added ileus to the Postmarketing Experience section of the Wegovy label under Gastrointestinal Disorders. In October 2025, Severe Gastrointestinal Adverse Reactions was added to the WARNING AND PRECAUTIONS section of the label

La plupart des lipases microbiennes sont stables dans de nombreux solvants organiques et ne requirent pas de co-facteur pour tre actives

Mol Genet Metab 109:20814